Colgate-Palmolive (India) Ltd. Share Price

Colgate Q2 FY27 revenue grows double-digit, margin slips

COLPAL reported its Q2 FY27 performance, showing accelerating top-line growth driven by a premium product mix and volume recovery. What happened: Colgate posted double-digit revenue growth for the second consecutive quarter. Toothpaste volume growth sustained a high-single-digit trajectory, supported by new product launches and a strategic push into premium offerings under managing director and CEO Manish Anandani. Gross margins expanded due to moderating raw material costs. However, EBITDA margins contracted because the company ramped up advertising and promotional spend by 368 basis points year-on-year, bringing ad costs to 18.6 percent of ***** it matters: The aggressive marketing spend is a deliberate defensive strategy. Colgate faces intensifying competition from D2C brands, rising incumbents, and shifting consumer preferences, which have challenged its traditional pricing power. By plowing savings from gross margins directly into brand building and premium positioning, the company is attempting to safeguard and expand its market share rather than maximize short-term ***** view: While the top-line recovery is encouraging, the market is currently penalizing the bottom-line compression. The stock has de-rated significantly to 30x FY28 estimated P/E from its 10-year average of over 40x due to margin erosion and subsequent downward earnings revisions. The headline focuses on growth, but misses the reality that heavy marketing dependency could become a structural drag on margins if competitive pressures persist without yielding permanent market share gains. What to watch next: Watch whether sustained double-digit growth can absorb elevated ad spending over the next two quarters, and look for signs of margin stabilization. View: Equal-weight. A valuation re-rating hinges on proof that heavy advertising drives durable growth rather than squeezed operational returns.

Colgate-Palmolive India falls to 52 week low after Q2

Colgate-Palmolive India fell 4.75% to a new 52 week low on 23 October 2026 as Q2 profit growth of 4.3% lagged revenue growth of 12.3%. Colgate-Palmolive (India) Limited [COLPAL] fell 4.75% to close at ₹1,605 on 23 October 2026, its sixth straight negative session. The stock also hit a new 52 week low of ₹1,580. The Q2 FY27 numbers showed a gap between sales and profit. Revenue rose 12.3% to ₹1,705.8 crore, but net profit grew only 4.3% to ₹341.6 crore. Operating margin slipped to about 28%, below estimates, as advertising spend rose. Several brokerages also trimmed target prices. The stock has fallen about 22% in 2026 and nearly 59% from its October 2024 peak. The daily chart shows a clear downtrend with lower highs and lower lows. The relative strength index is near 30, an oversold zone, which can lead to a pause but does not confirm a reversal. What next: Resistance is placed at ₹1,715 to ₹1,785. A close above this zone may ease selling pressure. Support is seen near ₹1,430. Until price reclaims resistance, the downtrend remains intact. Traders may also watch how brokerages react to the margin trend in coming weeks. Conclusion: The trend remains bearish until price closes above resistance. Disclosure & Disclaimer: I and my family members do not hold any position in the stock discussed. This content is provided solely for informational and educational purposes and should not be construed as investment advice or a recommendation to buy or sell any security. Investments in the securities market are subject to market risks. Please read all related documents carefully before investing.

Colgate’s 12% revenue growth masks margin pressure

Colgate-Palmolive (India) Limited (NSE: COLPAL) reported Q2 FY27 revenue of ₹1,706 crore, up 12.3% year-on-year. Net profit increased just 4.3% to ₹342 crore, missing market expectations. What happened? The oral-care company delivered high-single-digit volume growth in toothpaste, led by premium products and Colgate MaxFresh. However, EBITDA increased only 1.7% to ₹473 crore. EBITDA margin contracted to 27.8% from 30.6% a year earlier, a decline of 280 basis points. The company also declared an interim dividend of ₹24 per share, with 2 November 2026 as the record date. My analysis The most important signal is the divergence between revenue and profit growth. Volume growth suggests that consumer demand remains healthy, particularly in premium toothpaste. However, the sharp margin contraction indicates that higher sales are not translating proportionately into operating earnings. Interestingly, gross margin improved by 40 basis points to 69.6%. This suggests that pressure elsewhere in the cost structure, including increased brand investments and operating expenses, deserves closer attention

Colgate-Palmolive falls to two-year low despite Q2 growth

Colgate Palmolive (India) Limited shares fell as much as 5.76% to a fresh 52-week low despite Q2 profit growth of 4.3%. Support is at Rs 1,570. Colgate Palmolive (India) Limited [ COLPAL ] shares fell as much as 5.76% intraday on 23 October and hit a fresh 52-week low of Rs 1,588, a two-year low. It is the sixth straight session of losses. The stock traded at Rs 1,603.20 around 1:25 pm. Q2 profit rose 4.3% to Rs 341.6 crore from Rs 327.5 crore a year earlier. Revenue grew 12.3% to Rs 1,705.8 crore from Rs 1,519.5 crore. Revenue grew faster than profit. The update gives no margin data, so the reason for the fall cannot be tied to the results alone. The session opened at Rs 1,680.00 and touched a high of Rs 1,696.80 before selling set in. On the daily chart, the stock has fallen steeply from its peak and keeps making lower highs and lower lows. In my view, the trend is bearish, since a fresh low after six straight losses shows sellers in control. A fall below Rs 1,570 would put lower levels in view. A move above the Rs 1,720 resistance would weaken the bearish view and bring a recovery attempt into focus. Bearish view while price trades below Rs 1,720. Disclaimer: I do not hold any position in this. This content is for informational purposes only and is not a recommendation to buy or sell. Investments in securities are subject to market risks. Please read all related documents carefully before investing.

Colgate-Palmolive India Q2FY27 revenue up 12%, PAT rises 4%

COLPAL Colgate-Palmolive (India) Limited (COLPAL) has reported its Q2FY27 results. Total revenue stood at ₹1,705.79 crore, up 12.26% YoY and 6.39% QoQ. Total revenue was ₹1,705.79 crore versus ₹1,519.50 crore. EBITDA was ₹473.48 crore versus ₹465.43 crore (+1.73% YoY, -1.96% QoQ). EBITDA margin contracted to 27.76% from 30.63% YoY and 30.12% QoQ. PBT (excluding exceptional items) was ₹460.22 crore versus ₹442.28 crore (+4.06% YoY, -1.14% QoQ). PAT was ₹341.57 crore versus ₹327.51 crore (+4.29% YoY, -0.44% QoQ). Other income was ₹21.71 crore versus ₹15.03 crore YoY. The toothpaste portfolio delivered high-single-digit volume expansion, led by the Premium Toothpaste range and strong performance in Colgate MaxFresh. The board also declared an interim dividend of ₹24 per share. The key triggers are double-digit revenue growth and high-single-digit volume expansion in the toothpaste portfolio, though margin contraction limited profit growth. This reflects volume-led momentum supported by premiumisation, offset by higher brand investments. Peers in the oral care and personal care space such as Hindustan Unilever, Dabur, and Godrej Consumer Products may face comparison on volume growth and margin trends. Near-term prices could see a mixed reaction, with topline strength positive but margin pressure a watchpoint. Risks include sustained margin pressure from higher advertising spends or input costs, and slower volume growth in subsequent quarters. Competitors listed: Hindustan Unilever, Dabur, Godrej Consumer Products.

Colgate Q2: Sales Up 12%, Price Below Trendline

COLPAL reported Q2 FY27 net sales of Rs 1,692 crore, up 12.2% year-on-year, with H1 growth at 12.1%. Net profit rose 4.3% to Rs 341.6 crore (5.5% excluding one-offs), lagging sales because total expenses grew about 16%. Gross margin improved 40 basis points to 69.6%. Management said toothpaste delivered high-single-digit volume growth, led by the premium range and MaxFresh. An interim dividend of Rs 24 per share was declared, with a record date of 2 November. The shares settled near Rs 1,685, down about 2.3% on results day. On the monthly chart, the stock is more than 50% below its 2024 peak. It has moved below a rising trendline drawn from the 2016 low, as well as the 1,820 horizontal level, and RSI at 37.39 is weak. The month isn’t over, so the monthly close is what matters. A close below would confirm the breakdown, while a recovery above 1,820 would bring price back to the trendline. Support: 1,430-1,460 (2023 lows). Resistance: 1,820. Sales growth does not always become profit growth, and a monthly close, not a mid-month price, shows whether a long-term trendline has given way. Disclaimer: This is for educational purposes only and is not investment advice. Please consult your financial advisor before making any investment decisions. SEBI Registered Research Analyst — INH000025212. Source: Company Q2 FY27 results, as reported by Indian Television, inkl and Investywise.